RB
Regenimo Biosciences, Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$2Msold at filing
Total offering$2M
Investors in the raise6count reported to the SEC
FiledNov 25, 2025first sale Nov 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sharon ShachamExecutive Officer, Director
Lynda ChinDirector
Raju KucherlapatiDirector
Executive officers, directors and promoters as listed on the Form D.